i-JECT was chosen as a support task for clinical trial from Seoul National University Dental Hospital. 

There is a great news before lunar new year in Korea.

i-JECT was chosen as a support task for clinical trial from Seoul National University Dental Hospital and concluded an agreement. Seoul National University Dental Hospital well known for its best global network and prestige inside and outside of the country. And the Dental Hospital will run clinical tests for i-JECT in earnest.

i-JECT is classified to ‘class-II’, so it is not mandatory to have a clinical trial in Korea. However, in overseas market, depends on the country, it is mandatory to have one. 

Therefore, if we have the clinical trial in advance in Korea, we can save time and cost to enter other country markets. Also, we can secure public confidence for our product based on the clinical report.

Many thanks for the helps and supports to the professors and people concerned about it.

We will do our best to become No.1 painless automatic injector in Korea, and then move forward to overseas market.